Table III.

Presence of EGFR mutation/polymorphisms in malignant peritoneal mesothelioma tumor samples

Patient	Gender	Age (years)	c.2062–104C→A (Intronic change)	c.2284–60T→C (Intronic change)	Q787Q (c.2607 G→A) (Exon 20)	H850Y(c.2548 C→T) (Exon 21)	T903T (c.2709 T→C) (Exon 23)
1	M	65	Wt	Wt	Hm	Wt	Wt
2	F	71	Wt	Hz	Hz	Wt	Wt
3	F	51	Wt	Hz	Hm	Wt	Wt
4	M	41	Wt	Wt	Hz	Wt	Hz
5	M	58	Wt	Wt	Hz	H850Y	Hz
6	M	53	Hz	Wt	Hz	Wt	Wt
7	F	19	Wt	Hz	Hz	Wt	Hz
8	M	35	Wt	Wt	Hz	Wt	Wt
9	M	78	Wt	Hz	Hm	Wt	Wt
10	M	31	Wt	Wt	Hz	Wt	Wt
11	M	51	Wt	Wt	Hz	Wt	Wt
12	M	50	Wt	Wt	Hz	Wt	Hz
13	M	57	Wt	Wt	Wt	Wt	Wt
14	F	54	Wt	Wt	Hm	Wt	Hm
15	M	75	Wt	Wt	Wt	Wt	Wt
16	M	42	Wt	Hz	Hm	Wt	Wt
17	F	63	Wt	Wt	Hm	Wt	Hz
18	F	65	Wt	Wt	Wt	Wt	Hz
19	M	60	Wt	Wt	Hz	Wt	Wt
20	F	72	Wt	Wt	Hz	Wt	Hz
21	M	69	Wt	Wt	Hm	Wt	Wt
22	M	29	Wt	Hz	Hm	Wt	Wt
23	M	54	Wt	Wt	Hm	Wt	Wt
24	M	54	Wt	Wt	Hm	Wt	Wt
25	M	38	Wt	Wt	Hz	Wt	Wt
26	M	57	Wt	Wt	Hz	Wt	Wt
27	F	54	Wt	Wt	Hm	Wt	Wt
28	M	63	Wt	Wt	Hz	Wt	Wt
29	M	68	Wt	Wt	Hm	Wt	Wt
30	F	57	Wt	Wt	Hm	Wt	Wt
31	M	56	Wt	Wt	Hz	Wt	Hz
32	F	75	Wt	Wt	Hz	Wt	Wt
33	M	59	Wt	Wt	Hz	Wt	Hz

M, male; F, female; Wt, wild-type; Hz, heterozygous; Hm, homozygous.